BG
Bellevue Group Portfolio holdings
AUM
$5.28B
1-Year Est. Return
50.12%
This Fund
S&P 500
1 Year Est. Return
+50.12%
AUM
$5.28B
AUM Growth
+$464M
(+9.6%)
Holding
185
Top Buys
| 1 | +$120M | |
| 2 | +$105M | |
| 3 | +$102M | |
| 4 |
Krystal Biotech
KRYS
|
+$86.1M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$75.6M |
Top Sells
| 1 | +$149M | |
| 2 | +$139M | |
| 3 | +$113M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$109M |
| 5 |
argenx
ARGX
|
+$72.3M |
Sector Composition
| 1 | Healthcare | 99.71% |
| 2 | Technology | 0.1% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Financials | 0.03% |
| 5 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insulet
PODD
$17.1B
| $53.1M | 1.01% |
186,699
-25,306
|
|
||
27
Becton Dickinson
BDX
$49B
| $51.6M | 0.98% |
265,662
-31,232
|
|
||
|
JBIO
28
Jade Biosciences
JBIO
$675M
| $51.6M | 0.98% |
+3,341,103
|
|
||
29
Danaher
DHR
$142B
| $44.6M | 0.84% |
194,633
+30,757
|
|
||
30
Penumbra
PEN
$13.3B
| $42.1M | 0.8% |
135,395
-11,500
|
|
||
31
ResMed
RMD
$37.7B
| $38.8M | 0.74% |
161,214
-3,620
|
|
||
32
Edgewise Therapeutics
EWTX
$3.09B
| $37.9M | 0.72% |
1,528,518
-1,247,479
|
|
||
33
Thermo Fisher Scientific
TMO
$188B
| $37.7M | 0.71% |
65,077
-41,108
|
|
||
|
MAZE
34
Maze Therapeutics
MAZE
$2.13B
| $36.8M | 0.7% |
+887,708
|
|
||
35
Eli Lilly
LLY
$943B
| $36.5M | 0.69% |
34,003
-6,511
|
|
||
36
GE HealthCare
GEHC
$35.4B
| $34.8M | 0.66% |
424,514
-38,549
|
|
||
37
Tango Therapeutics
TNGX
$1.53B
| $34.8M | 0.66% |
+3,927,670
|
|
||
38
AbbVie
ABBV
$412B
| $30.8M | 0.58% |
134,859
-36,011
|
|
||
39
Cigna
CI
$72.2B
| $30.3M | 0.57% |
110,013
-12,473
|
|
||
40
Glaukos
GKOS
$6.69B
| $29.6M | 0.56% |
261,935
+206,009
|
|
||
41
Johnson & Johnson
JNJ
$592B
| $26.2M | 0.5% |
126,800
+51,993
|
|
||
42
Annexon
ANNX
$808M
| $25.9M | 0.49% |
5,157,290
|
|
||
43
Steris
STE
$23.7B
| $25.8M | 0.49% |
101,705
-16,407
|
|
||
44
Wave Life Sciences
WVE
$2.48B
| $25.3M | 0.48% |
1,490,518
-2,603,940
|
|
||
45
Elevance Health
ELV
$63.2B
| $24.4M | 0.46% |
69,645
-35,326
|
|
||
46
Cooper Companies
COO
$16.1B
| $23.9M | 0.45% |
291,959
-306
|
|
||
47
Globus Medical
GMED
$12B
| $22.9M | 0.43% |
262,683
-64,184
|
|
||
48
Align Technology
ALGN
$13B
| $22.1M | 0.42% |
141,474
-3,202
|
|
||
49
Zimmer Biomet
ZBH
$19.2B
| $21.5M | 0.41% |
238,680
-6,522
|
|
||
50
McKesson
MCK
$121B
| $20.6M | 0.39% |
25,098
-12,859
|
|